Novel Balloon Pulmonary Angioplasty Technique for Chronic Thromboembolic Pulmonary Hypertension.


Journal

International heart journal
ISSN: 1349-3299
Titre abrégé: Int Heart J
Pays: Japan
ID NLM: 101244240

Informations de publication

Date de publication:
2020
Historique:
entrez: 1 10 2020
pubmed: 2 10 2020
medline: 21 10 2020
Statut: ppublish

Résumé

This study aimed to clarify the usefulness of the Ikari-curve left (IL) guiding catheter for balloon pulmonary angioplasty (BPA).The current BPA strategy for chronic thromboembolic pulmonary hypertension is dilation of as many branches as possible to normalize hemodynamics and oxygenation. The shape of the guiding catheter is a major factor in achieving this. However, conventional guiding catheters are difficult to introduce into particular branches. The IL guiding catheter may be suitable; however, its utility remains unclear.We retrospectively analyzed 202 consecutive BPA sessions of 40 patients from November 2016 to October 2019 and divided these sessions into two groups: the IL group where the IL guiding catheter was used and the non-IL group where other catheters were utilized. The occurrence of lung injury was determined by the presence of bloody sputum. We compared the rates of successful introduction into target vessels and assessed for the occurrence of lung injury.The average age of enrolled patients was 60.3 ± 14.4 years, with females comprising 65%. There were 99 sessions in the IL group. The median treated branches per session differed between the 2 groups (IL group: 15 versus non-IL group: 10, P < 0.05). The occurrence of lung injury was lower in the IL group (4.0% versus 11.7%, P = 0.07). The IL group had more successful vessel insertions than the non-IL group (78.8% versus 42.7%, P < 0.01).The IL guiding catheter may be introduced into branches that cannot be accessed by conventional guiding catheters.

Identifiants

pubmed: 32999197
doi: 10.1536/ihj.20-280
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

999-1004

Auteurs

Shun Minatsuki (S)

Department of Cardiovascular Medicine Graduate School of Medicine, The University of Tokyo.

Arihiro Kiyosue (A)

Department of Cardiovascular Medicine Graduate School of Medicine, The University of Tokyo.

Satoshi Kodera (S)

Department of Cardiovascular Medicine Graduate School of Medicine, The University of Tokyo.

Kazutoshi Hirose (K)

Department of Cardiovascular Medicine Graduate School of Medicine, The University of Tokyo.

Akihito Saito (A)

Department of Cardiovascular Medicine Graduate School of Medicine, The University of Tokyo.

Hisataka Maki (H)

Department of Cardiovascular Medicine Graduate School of Medicine, The University of Tokyo.

Masaru Hatano (M)

Department of Therapeutic Strategy for Heart Failure, Graduate School of Medicine, The University of Tokyo.

Eiki Takimoto (E)

Department of Cardiovascular Medicine Graduate School of Medicine, The University of Tokyo.

Jiro Ando (J)

Department of Cardiovascular Medicine Graduate School of Medicine, The University of Tokyo.

Issei Komuro (I)

Department of Cardiovascular Medicine Graduate School of Medicine, The University of Tokyo.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH